Pharmaceutical industry - sales growth by therapeutic classes
These statistic shows the sales growth of selected pharmaceutical major therapeutic classes in 2010. In that year, sales of antidiabetics grew 12.2 percent.
Sales growth of selected pharmaceutical major therapeutic classes in 2010
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Pharmaceutical industry in Spain
Overview
6
- Premium Statistic Revenues of top 10 global pharmaceutical markets 2023
- Premium Statistic Top global pharmaceutical markets: growth rate 2023
- Premium Statistic Value of pharmaceutical sales in Spain 2010-2022
- Premium Statistic Pharmaceutical market in Spain 2023, by segment
- Basic Statistic Pharmacies in Spain 2007-2022
- Basic Statistic Employees in the Spanish pharmaceutical industry 2008-2021
International trade
6
- Premium Statistic Value of pharmaceutical products exported from Spain 2002-2022
- Premium Statistic Pharmaceutical imports in Spain 2002-2023
- Premium Statistic Export value of pharmaceutical products in Spain 2023, by type
- Premium Statistic Import value of pharmaceutical products in Spain 2023, by type
- Premium Statistic Pharmaceutical exports value in Spain 2023, by country of destination
- Premium Statistic Pharmaceutical imports value in Spain 2023, by country of origin
Pharmaceutical sales
6
- Premium Statistic Net sales of drugs in pharmacies in Spain 2012-2022
- Premium Statistic Net value of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Value share of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Volume of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Volume share of drugs sold in pharmacies in Spain 2022, by therapeutic group
- Premium Statistic Average price of drugs sold in pharmacies in Spain 2022, by therapeutic group
Pharmaceutical expenditure of the National Health System
6
- Premium Statistic Budget expenditure on health benefits & pharmacy in Spain 2003-2024
- Premium Statistic NHS expenditure on prescribed medicines in pharmacies in Spain 2010-2021
- Premium Statistic Average cost of medical prescriptions in pharmacies in Spain 2010-2021
- Premium Statistic State-funded drug prescriptions dispensed in pharmacies in Spain 2010-2021
- Premium Statistic NHS expenditure per prescription dispensed in pharmacies in Spain 2021, by region
- Premium Statistic Share of per capita pharmaceutical expenditure in Spain 2021, by region
Research and development
6
- Premium Statistic Share of total R&D spending in Spain in 2021, by industrial sector
- Premium Statistic R&D expenditure in the pharmaceutical industry in Spain 2008-2022
- Premium Statistic R&D employment within the pharmaceutical industry in Spain 2008-2022
- Premium Statistic Pharmaceutical R&D spending in Spain 2022, by type
- Premium Statistic Internal and external R&D expenditure in the pharmaceutical industry Spain 2012-2022
- Premium Statistic External R&D expenditure in the pharmaceutical industry Spain 2022, by region
Company rankings
6
- Premium Statistic Leading basic pharmaceutical products manufacturers in Spain in 2021
- Premium Statistic Leading pharmaceutical preparations manufacturers in Spain in 2021
- Premium Statistic Leading pharmaceutical goods wholesalers in Spain in 2021
- Premium Statistic Corporate reputation of leading pharmaceutical companies in Spain in 2023
- Premium Statistic Leading companies in R&D on biotechnology in Spain 2021
- Basic Statistic Largest private capital increases of biotech companies in Spain 2021
Further related statistics
9
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Cvs Health total assets 2019-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Cvs Health total assets 2019-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$959 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Pharmaceutical Executive. (May 16, 2011). Sales growth of selected pharmaceutical major therapeutic classes in 2010 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/273034/sales-growth-of-therapeutic-classes-in-2010/
Pharmaceutical Executive. "Sales growth of selected pharmaceutical major therapeutic classes in 2010." Chart. May 16, 2011. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/273034/sales-growth-of-therapeutic-classes-in-2010/
Pharmaceutical Executive. (2011). Sales growth of selected pharmaceutical major therapeutic classes in 2010. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/273034/sales-growth-of-therapeutic-classes-in-2010/
Pharmaceutical Executive. "Sales Growth of Selected Pharmaceutical Major Therapeutic Classes in 2010." Statista, Statista Inc., 16 May 2011, https://www-statista-com.ezproxy.canberra.edu.au/statistics/273034/sales-growth-of-therapeutic-classes-in-2010/
Pharmaceutical Executive, Sales growth of selected pharmaceutical major therapeutic classes in 2010 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/273034/sales-growth-of-therapeutic-classes-in-2010/ (last visited November 10, 2024)
Sales growth of selected pharmaceutical major therapeutic classes in 2010 [Graph], Pharmaceutical Executive, May 16, 2011. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/273034/sales-growth-of-therapeutic-classes-in-2010/